Filing Details
- Accession Number:
- 0001179110-21-008255
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-18 15:17:34
- Reporting Period:
- 2021-08-16
- Accepted Time:
- 2021-08-18 15:17:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 896264 | Usana Health Sciences Inc | USNA | Medicinal Chemicals & Botanical Products (2833) | 870500306 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1298819 | A Robert Sinnott | 3838 West Parkway Blvd Salt Lake City UT 84120 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-08-16 | 1,648 | $65.48 | 1,648 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-08-16 | 1,648 | $95.04 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-08-17 | 7,492 | $65.48 | 7,492 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-08-17 | 7,492 | $94.00 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Settled Appreciation Rights | Disposition | 2021-08-16 | 5,304 | $0.00 | 5,304 | $65.48 |
| Common Stock | Stock Settled Appreciation Rights | Disposition | 2021-08-17 | 24,696 | $0.00 | 24,696 | $65.48 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 24,696 | 2021-08-16 | 2022-03-16 | No | 4 | M | Direct |
| 0 | 2021-08-16 | 2022-03-16 | No | 4 | M | Direct |
Footnotes
- The shares acquired resulted from the reporting persons settlement of the stock-settled stock appreciation rights disclosed in Table II.
- Weighted average price $95.04 Price range in multiple transactions was $95.02 to $95.05 inclusively.
Billionaire Hedge Funds
